Introduction
Chronic myeloid leukemia (CML) is a stem-cell disorder characterized by chronic and blast-crisis phases. Emerging evidence indicates that leukemia stem-cell (LSC) compartment including that of CML is dynamic owing to its exquisite adaptability. [1] [2] [3] Interestingly, presence of BCR-ABL-containing CD34 þ cells in patients with cytogenetic remission under imatinib 4 suggests involvement of BCR-ABL-independent signaling exploited by the LSCs. However, the molecular program controlling hematopoietic stem-cell (HSC) self-renewal, Notch, Sonic hedgehog (Shh), Wnt and Hox signaling are also involved in oncogenesis. 5, 6 Additionally, the cell cycle regulators p21 and p27 control HSC quiescence and progenitor proliferation, respectively. 7, 8 Nevertheless, global elucidation of the molecular mechanisms orchestrating these multiple signaling pathways in the stem-cell self-renewal transcriptional program might explore CML progression. Deregulation in Hedgehog signaling, which regulates tissue patterning and stem-cell maintenance, is associated with different forms of human cancer. 9 Shh may even function as a regulator of HSC depending on downstream signals. 10 Then again, aberrant Notch signaling is also involved in hematopoietic malignancies. 11 Direct protein-protein interactions between Stat3 and Hes1 have been suggested to link Jak-Stat and NotchHes pathways. 12 Moreover, contemporary studies suggest regulatory role of Notch in repressing p27 activity. 13, 14 Notably, enhanced clonogenicity and poor prognosis have been associated with activation of canonical Wnt signaling in several types of leukemia. 15, 16 Moreover, results arising from the experimental interference in some of these pathways signify the importance of the network in designing therapeutic modalities. [17] [18] [19] Nevertheless, to address the dynamic stem-cell compartment, we compared the gene expression and signaling for this apparently diverse but mutually interconnected self-renewalassociated genetic programs of CD34 þ chronic phase and blastcrisis CML cells. We demonstrate that Stat3, Gli3, b-catenin, CyclinD1, Hes1, HoxA10 and p21 play important role in the signaling network.
Materials and methods

Reagents
Cytokines and recombinant proteins. Stem-cell factor (SCF), Flt-3-ligand, interleukin-3 (IL-3), recombinant Wnt3a and N-Shh (C24II) were purchased from R&D Systems Inc., Minneapolis, MN, USA.
Antibodies
Rabbit anti-pY705-Stat3/Stat3, anti-pT308-Akt/Akt, anti-pT202/ Y204-p44/42 mitogen activated protein kinase (MAPK)/p44/42, anti-pS9-GSK-3b/GSK-3b, anti-b-catenin, anti-b-actin and goat anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody were purchased from Cell Signaling Technology (Beverly, MA, USA).
Drugs
Forskolin was purchased from Calbiochem (Merck Ltd, USA) and Cyclopamine from Cyanochem, and they were dissolved in dimethyl sulfoxide and ethanol, respectively.
Plasmids
The p27-PF-luc and pGVB2-luc reporter constructs were obtained from T. Sakai (Molecular-Targeting Cancer Prevention, Japan). The 1745-cyclinD1-luc and pA2-luc reporters were gifted by C Albanese (Lombardi Cancer Center, WA). The pTOPFLASH and pFOPFLASH reporters were obtained from H Clevers (Hubrecht Laboratory, Utrecht, The Netherlands). Stat3C and M67-luc were gifted by J Bromberg (Memorial Sloan-Kettering Cancer Center, NY). We also obtained dominant negative Stat3b from J Clifford (Meso scale Discovery, NY). In addition, different constructs of Notch1 were from J Aster (Harvard Medical School, MA, USA) and T Kadesch (University of Pennsylvania, School of Medicine, PA, USA).
CML patient samples and CD34
þ progenitor culture þ cells were cultured in Iscove's Modified Dulbecco's Medium in presence of 10% fetal calf serum (FCS) supplemented with SCF (100 ng/ ml), Flt-3-ligand (100 ng/ml), IL-3 (10 ng/ml) and Wnt3a (500 ng/ ml) or N-Shh (3 mg/ml) (All from Stem cell technologies Inc., Canada). Details are available in Supplementary Information.
qRT-PCR
RNA was isolated from bone marrow samples of individual CP CML patients and from either bone marrow or peripheral blood of BP CML patients. Total RNA was extracted from CD34 þ cells using Tripure isolation reagent (TRIZOL, Roche, GmbH, Mannheim, Germany) and subsequently treated with RNAsefree DNAse (DNAfree Ambion, Austin, TX, USA) and qualityassayed (Eppendorf BioPhotometer, Germany). The cDNA was prepared by reverse transcribing 50 ng of total RNA with Taqman reverse transcriptase reagents (Applied Biosystems, Foster City, CA, USA). Quantitative PCR was subsequently performed using SYBR Green core PCR reagents (Applied Biosystems) and HPRT1 was used as the endogenous control. The qRT-PCR reactions and analyses were carried out in 7500 Sequence Detection System (Applied Biosystems). Details are available in Supplementary Information and sequences of respective intron spanning primer pairs are included in the Supplementary Table 2 .
Western blot analysis
Cells were harvested and lysates recovered by centrifugation. Estimated amount of proteins were separated by 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred on nitrocellulose. Blots were probed with respective primary and HRP-conjugated secondary antibodies and developed by using ECL detection system (Amersham Biosciences, Pittsburgh, PA, USA). Densitometry was used for quantitation (Bio-Rad, Hercules, CA, USA).
Nucleofection
CD34
þ primary cells were nucleofected either with reporter constructs or plasmids according to the manufacturer's recommendations (AMAXA Inc, Gaithersburg, MD, USA). Details are available in Supplementary Information.
Luciferase assay
For determining the luciferase activity, CD34
þ cells were cotransfected with respective reporter constructs (5 mg) together with phRL control vector (1 mg). Relative luciferase unit (RLU) was determined by normalizing phRL-null using Dual luciferase assay kit (Promega, MA, USA).
Statistical analysis
The gene expression levels in CP and BP CML were compared by unpaired two-tailed t-test. Only a Po0.001 was considered statistically significant. In addition, results obtained from multiple experiments were reported as the mean7s.e.m.
Results
Distinct gene expression and reporter activity in CD34
þ chronic and blast-crisis CML cells þ CP CML cells (Figure 2c) . Surprisingly, expression of CyclinD1, Ptc1 and Gli1, but neither Gli3 nor p21, was repressed when CD34 þ CP CML cells were cultured in presence of forskolin (200 mM) (Figure 2d ).
Shh signaling regulates Stat3 activation in CD34
þ CML cells
To address the deregulation observed in Shh-induced gene expression, we analyzed downstream signaling pathways. 
Stat3-dependent gene expression induces cross talk in CD34
þ CML cells (Figure 4) . However, it neither induced HoxA10, HoxB4 nor Notch target genes: Hes1, Hes5 and Hey1. We also noticed Stat3C-driven increase in Shh transcript in one of the CML samples studied (data not shown).
Deregulation of Wnt signaling in CD34
þ CML
To investigate Wnt signaling, CD34 þ CML cells were cultured in presence or absence of saturating concentration of soluble Wnt3a (500 ng/ml) for 24 h. Compared to CP, BP CML cells showed significant increase in both CyclinD1 and c-Myc transcripts, however, expression of b-catenin and Lef1 was unaltered (Figure 5a ). Interestingly, Wnt3a induced expression of Gli1 and Gli3 transcripts in chronic phase, but it did not induce expression of Hes5 and HoxA10 (Figure 5a ). In addition, compared to chronic phase, expression of Ptc1 was more induced in CD34
þ BP CML cells as a result of Wnt3a signaling (Figure 5a ). Western blot analysis reveals upregulation of b-catenin in CD34
þ CP CML cells within 24 h of treatment with Wnt3a (Figure 5b ). This increase in b-catenin protein is accompanied by concomitant rise in phosphorylated glycogen synthetase kinase-3b (GSK-3b), which suggests activation of the canonical Wnt/b-catenin axis (Figure 5b) . However, identical dose of Wnt3a did neither induce phosphorylated-Stat3 (Y705) nor total Stat3 protein in CD34
þ CP CML cells (Figure 5b ).
Discussion
The objective of CML stem-cell biology is to decipher BCR-ABLindependent signaling exploited by the progenitors to reacquire self-renewal characteristics. Previous studies have highlighted the role of Hox pathway in HSC maintenance. [20] [21] [22] [23] [24] It has been suggested that overexpression of HoxA10 might have both prodifferentiation and antidifferentiation properties in a dose- 
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þ CML cells A Sengupta et al dependent spatiotemporal manner. 21, 22 In contrast, overexpression of HoxB4 in HSC enhances in vivo lympho-myeloid regeneration without impairing normal differentiation or inducing cellular transformation. 23, 24 Given that CML blast crisis is characterized by differentiation blockage, the reduced HoxA10 and HoxB4 transcripts in CD34 þ BP CML cells might reflect the deregulation in Hox pathway that warrants future investigation. In addition, we detected upregulation in Fzd2, Lef1, b-catenin, CyclinD1 and Ptc1 transcripts in BP CML. Transcriptional increase in Fzd2 and Ptc1, the receptors for Wnt and Shh signaling, respectively, indicate activation of these pathways in blast crisis as Ptc1 itself is a target of the Shh signaling. Furthermore, significant increase in Ptc1 transcript in blast crisis is not always associated with that of Gli3, which is another target of Shh pathway activation. Taken together, this indicates that CML progression is associated with deregulation in Shh signaling.
We compared Shh and Wnt3a-induced signaling in CD34 þ CP and BP CML cells cultured in vitro. Interestingly, we find Shh signaling induces Stat3 activation in chronic phase cells that could be inhibited by the smoothened inhibitor cyclopamine. However, unlike Shh-dependent Akt activation, as observed in NIH3T3 cells, 25 we did not get either PI3K-Akt or p44/42-MAPK activation. This indicates that Shh-dependent Stat3 activation is a specific event. Again, we could not detect Shh-induced Stat3 activation in blast crisis possibly owing to the presence of high level of phosphorylated Stat3. 26 However, the precise mechanism by which Shh induces Stat3 phosphorylation still remains to be identified. Interestingly, forskolin, an activator of protein kinase A (PKA) and thus inhibitor of Shh signaling, inhibits activation of Ptc1 and Gli1, but maintains upregulated Gli3 transcript. This may suggest that the complicated regulation of Gli3 transcription is indirect and that is either independent or upstream of PKA function.
In addition, compared to CP, Shh induces significant upregulation of CyclinD1 and p21 transcripts in CD34 þ BP CML cells. Forskolin inhibition was not even able to repress induction of CyclinD1 transcript. We compared constitutive active Stat3C-dependent regulation of gene expression in CD34
þ CP CML cells with respect to the dominant negative Stat3b. Remarkably, Stat3C induced expression of Wnt3a, Lef1, CyclinD1, p21, p27 and Gli1. However, it did not induce HoxA10, HoxB4 and Notch target genes: Hes1, Hes5 and Hey1. Interestingly, Stat3C-dependent increase in Wnt3a could be the plausible way of transformation from paracrine to autocrine signaling. Recently, it has been suggested that Stat3 transcriptionally regulates CyclinD1 in breast carcinoma cells. 27 Moreover, nuclear accumulation of b-catenin is associated with Stat3 activation in colorectal cancer. 28 Altogether, our data demonstrates that Shh-dependent Stat3 activation and Stat3 dependence 
of CD34
þ CML cells not only interconnect Shh, Wnt, Notch and Hox pathways, but also paves BCR-ABL-independent signaling pathway for CML progression ( Figure 6 ).
We report increase in p21 transcript in untreated CD34 þ BP CML cells. Furthermore, Shh, Wnt and Stat3 signaling independently regulate expression of p21 and p27. Although high level of p21 mRNA has been reported in bone marrow mononuclear cells, 7 it is not increased in CD34 þ cells during normal þ CML cells necessitates BCR-ABL-independent mechanism in connecting Shh and Wnt pathways through upregulation of CyclinD1 and Lef1, which eventually leads to uncontrolled proliferation. It might also lead to paracrine (generally signaling cues are provided by the bone marrow microenvironment) to autocrine loop transformation by inducing Wnt3a itself. In addition, Wnt3a-mediated upregulation in Ptc1 could be another plausible mechanism of such regulatory cross talk in CML progression.
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þ CML cells A Sengupta et al hematopoiesis. This may reflect the complex biochemical role p21 plays as either a requisite participant in the formation of a cyclin-dependent kinase (CDK) complex, necessary for G1-S progression, or as a CDK inhibitor (CDKI). On the other hand, p27 is regulated both at the transcriptional and posttranslational level, and earlier we have shown that modifying p27 could have a therapeutic role in CML. 19 All these suggest that p21 and p27 play distinct roles depending on the subcompartments of the hematopoietic cascade. Nevertheless, LSC may exploit these subtleties necessary for HSC maintenance 29 in making deregulated p21 and p27 for CML progression.
Additionally, enhanced level of Lef1, b-catenin and CyclinD1 transcripts along with increased Tcf4-dependent reporter activity are consistent with the activation of Wnt signaling in blast crisis. In contrast, we did not observe increase in c-Myc transcript, which is another important target of canonical Wnt pathway. Recently, c-Myc has been identified as a direct and major Notch1 target in T-cell leukemia. 30 Notably, Notch pathway has recently been shown to regulate embryonic neural stem-cell number by modulating Stat3 activation. 31 Here, the gene expression data demonstrate that Notch signaling is not hyperactivated, if not downregulated, in CD34
þ BP CML cells. Taken together, this suggests that even though Wnt/b-catenin axis is activated, owing to deregulated Notch signaling, c-Myc transcript could not get increased. Moreover, Wnt3a-induced upregulation in c-Myc transcript in blast crisis is an indicative of overcoming the Notch-dependency. Furthermore, Wnt3a-induced expression of Gli1 and Gli3 selectively in CP CML reflects the cross talk similar to the de novo gene expression pattern.
Altogether, we have identified a distinct gene expression profile of self-renewal-associated signaling of CD34 þ CML cells. Unlike CP CML cells, some samples of BP were isolated from peripheral blood rather than bone marrow. Earlier study conducted on normal HSC indicates that in contrast to bone marrow resident CD34 þ cells, circulating peripheral CD34 þ population consists of a higher number of quiescent stem and progenitor cells. 32 However, it has been recently demonstrated that in BCR-ABL þ CML cells, proliferating status and gene expression pattern are similar and extremely well correlated irrespective of the origin of these CD34 þ cells. 33, 34 Furthermore, discrepancies may also arise from the differential karyotype of CML and efforts were therefore made to ensure that analysis were carried out only on CML samples containing more than 95% Philadelphia (Ph) chromosome in metaphase. Recent studies have focused on the gene expression of CML using microarray indicating biphasic nature of the disorder and the involvement of the Wnt/b-catenin pathway that corroborates our findings. 34, 35 However, considering posttranscriptional and posttranslational modifications, gene expression signature might not be the only choice to pursue. Significantly, the novel findings of our study based on an integrated approach do not merely represent the gene-by-gene or signal-to-signal quantitation but put a step toward contemporary molecular dissection of tumor cells to understand the complexity and subtlety of the signaling networks that drive and maintain them. Nevertheless, there remains an immense scope for studying the consequence of such ramified signaling network particularly in the field of regenerative and preventive medicine.
